Global Ovarian Cancer Diagnostics Market by Cancer Type (Epithelial Tumor, Germ Cell Tumor, Stromal Cell Tumor), Diagnosis Type (Biopsy, Blood Test, Imaging), End-User - Forecast 2024-2030- Product Image

Sale

Global Ovarian Cancer Diagnostics Market by Cancer Type (Epithelial Tumor, Germ Cell Tumor, Stromal Cell Tumor), Diagnosis Type (Biopsy, Blood Test, Imaging), End-User - Forecast 2024-2030

Report
195 Pages
March 2024
Region: Global
360iResearch™
ID: 5674412

UP TO €846EUR$875USD£717GBP OFF until Dec 31^st 2024

The Ovarian Cancer Diagnostics Market size was estimated at USD 7.17 billion in 2023, USD 8.18 billion in 2024, and is expected to grow at a CAGR of 14.50% to reach USD 18.50 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Ovarian Cancer Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Ovarian Cancer Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Ovarian Cancer Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Ltd., Almac Group, Apollo Diagnostics, AstraZeneca PLC, Avalon Health Economics LLC, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Laboratory Corporation of America Holdings, MedGenome Labs Ltd., Myriad Genetics Inc., Oncgnostics GmbH, Ovation Diagnostics LLC, Pfizer, Inc., and Thermo Fisher Scientific Inc.

Market Segmentation & Coverage

This research report categorizes the Ovarian Cancer Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
Diagnosis Type
- Biopsy
- Blood Test
  - BRCA
  - CA125
  - CEA
  - ER & PR
  - HER2
  - KRAS Mutation
- Imaging
  - CT Scan
  - MRI Scan
  - PET Scan
  - Ultrasound
End-User
- Cancer Diagnostic Centers
- Hospital Laboratories
- Research Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Ovarian Cancer Diagnostics Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Ovarian Cancer Diagnostics Market?
What are the technology trends and regulatory frameworks in the Ovarian Cancer Diagnostics Market?
What is the market share of the leading vendors in the Ovarian Cancer Diagnostics Market?
Which modes and strategic moves are suitable for entering the Ovarian Cancer Diagnostics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Ovarian Cancer Diagnostics Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing favorable government initiatives and growing funding for ovarian cancer research
5.1.1.2. Growing prevalence of ovarian cancer among women worldwide
5.1.1.3. Potential demand for early diagnosis and treatment
5.1.2. Restraints
5.1.2.1. Relatively high cost of diagnosis and concerns of adverse effects of the treatment among patients
5.1.3. Opportunities
5.1.3.1. Emerging modernization and advancements in technical diagnostic tools for ovarian cancer
5.1.3.2. Ongoing application of combination therapies to treat ovarian cancer
5.1.4. Challenges
5.1.4.1. Reduced awareness and dearth of precise diagnosis of ovarian cancer
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Ovarian Cancer Diagnostics Market, by Cancer Type

6.1. Introduction
6.2. Epithelial Tumor
6.3. Germ Cell Tumor
6.4. Stromal Cell Tumor

7. Ovarian Cancer Diagnostics Market, by Diagnosis Type

7.1. Introduction
7.2. Biopsy
7.3. Blood Test
7.4.1. BRCA
7.4.2. CA125
7.4.3. CEA
7.4.4. ER & PR
7.4.5. HER2
7.4.6. KRAS Mutation
7.4. Imaging
7.5.1. CT Scan
7.5.2. MRI Scan
7.5.3. PET Scan
7.5.4. Ultrasound

8. Ovarian Cancer Diagnostics Market, by End-User

8.1. Introduction
8.2. Cancer Diagnostic Centers
8.3. Hospital Laboratories
8.4. Research Institutes

9. Americas Ovarian Cancer Diagnostics Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Ovarian Cancer Diagnostics Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Ovarian Cancer Diagnostics Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. Abbott Laboratories Ltd.
13.1.2. Almac Group
13.1.3. Apollo Diagnostics
13.1.4. AstraZeneca PLC
13.1.5. Avalon Health Economics LLC
13.1.6. Becton, Dickinson and Company
13.1.7. Bio-Rad Laboratories, Inc.
13.1.8. F. Hoffmann-La Roche AG
13.1.9. GlaxoSmithKline PLC
13.1.10. Laboratory Corporation of America Holdings
13.1.11. MedGenome Labs Ltd.
13.1.12. Myriad Genetics Inc.
13.1.13. Oncgnostics GmbH
13.1.14. Ovation Diagnostics LLC
13.1.15. Pfizer, Inc.
13.1.16. Thermo Fisher Scientific Inc.
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. OVARIAN CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. OVARIAN CANCER DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
FIGURE 8. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2023 VS 2030 (%)
FIGURE 10. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. OVARIAN CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. OVARIAN CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. OVARIAN CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 6. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY EPITHELIAL TUMOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY GERM CELL TUMOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY STROMAL CELL TUMOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 10. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 13. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BRCA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CA125, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY ER & PR, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY HER2, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY KRAS MUTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 21. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CT SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY MRI SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY PET SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. CANADA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 46. CANADA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 47. CANADA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 48. CANADA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 49. CANADA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. MEXICO OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 51. MEXICO OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 52. MEXICO OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 53. MEXICO OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 54. MEXICO OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. CHINA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 73. CHINA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 74. CHINA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 75. CHINA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 76. CHINA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. INDIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 78. INDIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 79. INDIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 80. INDIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 81. INDIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. JAPAN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 88. JAPAN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 89. JAPAN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 90. JAPAN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 91. JAPAN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. THAILAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 118. THAILAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 119. THAILAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 120. THAILAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 121. THAILAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 133. DENMARK OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 134. DENMARK OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 135. DENMARK OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 136. DENMARK OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 137. DENMARK OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. EGYPT OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 139. EGYPT OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 140. EGYPT OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 141. EGYPT OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 142. EGYPT OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. FINLAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 144. FINLAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 145. FINLAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 146. FINLAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 147. FINLAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. FRANCE OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 149. FRANCE OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 150. FRANCE OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 151. FRANCE OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 152. FRANCE OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. GERMANY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 154. GERMANY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 155. GERMANY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 156. GERMANY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 157. GERMANY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. ITALY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 164. ITALY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 165. ITALY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 166. ITALY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 167. ITALY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. NORWAY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 179. NORWAY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 180. NORWAY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 181. NORWAY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 182. NORWAY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. POLAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 184. POLAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 185. POLAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 186. POLAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 187. POLAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. QATAR OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 189. QATAR OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 190. QATAR OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 191. QATAR OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 192. QATAR OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 208. SPAIN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 209. SPAIN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 210. SPAIN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 211. SPAIN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 212. SPAIN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 223. TURKEY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 224. TURKEY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 225. TURKEY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 226. TURKEY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 227. TURKEY OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM OVARIAN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 238. OVARIAN CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 239. OVARIAN CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 240. OVARIAN CANCER DIAGNOSTICS MARKET LICENSE & PRICING

Companies Mentioned

Abbott Laboratories Ltd.
Almac Group
Apollo Diagnostics
AstraZeneca PLC
Avalon Health Economics LLC
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche AG
GlaxoSmithKline PLC
Laboratory Corporation of America Holdings
MedGenome Labs Ltd.
Myriad Genetics Inc.
Oncgnostics GmbH
Ovation Diagnostics LLC
Pfizer, Inc.
Thermo Fisher Scientific Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	195
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 8.18 Billion
Forecasted Market Value ( USD ) by 2030	$ 18.5 Billion
Compound Annual Growth Rate	14.5%
Regions Covered	Global
No. of Companies Mentioned	16

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3263EUR$3,374USD£2,763GBP €3625EUR$3,749USD£3,070GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4133EUR$4,274USD£3,500GBP €4593EUR$4,749USD£3,889GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5004EUR$5,174USD£4,238GBP €5560EUR$5,749USD£4,708GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5874EUR$6,074USD£4,975GBP €6527EUR$6,749USD£5,527GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7615EUR$7,874USD£6,449GBP €8461EUR$8,749USD£7,165GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Ovarian Cancer Diagnostics And Therapeutics Market Report and Forecast 2024-2032

Ovarian Cancer Diagnostics Global Market Report 2024

Cancer Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Companies Analysis

Hereditary Breast and Ovarian Cancer Syndrome Treatment Global Market Report 2024

Cancer Diagnostics Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030